602 results on '"Mishra, Asmita"'
Search Results
2. Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant
3. A cumulative study on pyrolysis of waste motor oil exploring the design and development of a fixed-bed laboratory scale setup with emphasis on process parameter optimization, COMSOL simulation and preliminary risk assessment
4. Optimization and screening of process parameters for the robust co-pyrolytic study of waste motor oil and rice stubble toward sustainable waste-to-fuel generation
5. An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
6. Interpreting crystallographic and microcrystalline structural effect for demineralization of low-grade thermal coal in multi-stage chemical leaching: A cleaner combustion approach
7. In-situ synthesis of efficient ZnCl2 doped pyrolyzed biochar for adsorptive remediation of organic dyes: Performance evaluation, mass transfer and mechanism
8. Melphalan Dose in Combination With Fludarabine Affects Gastrointestinal Toxicity and Graft-Versus-Host Disease After Allogeneic Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndromes
9. JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results
10. Optimization of process parameters for waste motor oil pyrolysis towards sustainable waste-to-energy utilizing a combinatorial approach of response surface methodology and desirability criteria
11. Lower Weight-Based Mycophenolate Mofetil Dosing is Associated with Superior Outcomes after Haploidentical Hematopoietic Cell Transplant with Post-transplant Cyclophosphamide
12. Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma
13. In-situ and ex-situ co-pyrolysis studies of waste biomass with spent motor oil: Elucidating the role of physical inhibition and mixing ratio to enhance fuel quality
14. Strategic implementation of integrated bioaugmentation and biostimulation for efficient mitigation of petroleum hydrocarbon pollutants from terrestrial and aquatic environment
15. Kinetic studies on the potential use of citrus-based green and low-cost demulsifying agents for the oil-in-water emulsions' treatment
16. A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease
17. Objective and subjective physical function in allogeneic hematopoietic stem cell transplant recipients
18. Elucidating Sustainable Waste Management Approaches along with Waste-to-Energy Pathways
19. Mismatched donor allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide achieves comparable outcomes between racially and ethnically diverse patient populations
20. Increased Infections and Delayed CD4+ T Cell but Faster B Cell Immune Reconstitution after Post-Transplantation Cyclophosphamide Compared to Conventional GVHD Prophylaxis in Allogeneic Transplantation
21. Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
22. Pyrolysis of waste lubricating oil/waste motor oil to generate high-grade fuel oil: A comprehensive review
23. A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention
24. List of contributors
25. Microbial biodiesel: a comprehensive study toward sustainable biofuel production
26. A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation
27. Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide
28. Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3
29. The Transplantation Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Transplantation Patients
30. Association of Patient-Reported Physical Activity on Allogeneic Hematopoietic Cell Transplant Outcomes
31. Extensive thermogravimetric and thermo-kinetic study of waste motor oil based on iso-conversional methods
32. A synergistic study of reaction kinetics and heat transfer with multi-component modelling approach for the pyrolysis of biomass waste
33. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report
34. Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host Disease
35. JAK2/mTOR Inhibition Fails to Prevent Acute Gvhd Despite Reduced Th1/Th17 Cells: Final Phase II Trial Results
36. Outcomes of Haploidentical Stem Cell Transplant Recipients with HHV-6 Reactivation Receiving Antiviral Therapy
37. Phase II Trial of Reduced-Intensity Fludarabine, Melphalan 70 Mg/m2, and Total Body Irradiation Conditioning Results in Favorable Outcomes with Haploidentical Donor Peripheral Blood Stem Cell Transplant
38. Expanded Antigen-Specific Donor Regulatory T Cells for Gvhd Prevention
39. Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102
40. Attitude of youth towards the skill India scheme in Ayodhya district of Uttar Pradesh
41. Approaches to optimize outcomes in transplant recipients
42. Outcome of patients with low‐risk and intermediate‐1‐risk myelodysplastic syndrome after hypomethylating agent failure: A report on behalf of the MDS Clinical Research Consortium
43. Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3.
44. Sirolimus is an acceptable alternative to tacrolimus for graft-versus-host disease prophylaxis after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide
45. In-situ synthesis of efficient ZnCl2 doped pyrolyzed biochar for adsorptive remediation of organic dyes: Performance evaluation, mass transfer and mechanism
46. Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
47. Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation
48. P1540: COVID-19 INFECTION AMONG CAR-T CELL THERAPY RECIPIENTS: A SINGLE CENTER EXPERIENCE
49. TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
50. Application of Artificial Neural Network (ANN) as a predictive tool for the removal of pharmaceutical from wastewater streams using biochar: a multifunctional technology for environment sustainability.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.